These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 6763968)
1. Susceptibility of the host--role of non-genetic factors. Dharmendra Lepr India; 1982 Oct; 54(4):721-82. PubMed ID: 6763968 [No Abstract] [Full Text] [Related]
2. An appraisal of medical research in the treatment and control of leprosy. Rees RJ Lepr India; 1982 Oct; 54(4):783-800. PubMed ID: 6763969 [No Abstract] [Full Text] [Related]
3. Antigens of Mycobacterium leprae in urine during treatment of patients with lepromatous leprosy. Olcén P; Harboe M; Warndorff van Diepen T Lepr Rev; 1986 Dec; 57(4):329-40. PubMed ID: 3540495 [No Abstract] [Full Text] [Related]
4. A candidate anti-leprosy vaccine from ICRC bacilli. Deo MG; Chaturvedi RM; Kartikeyan S Trop Med Parasitol; 1990 Sep; 41(3):367-8. PubMed ID: 2255866 [No Abstract] [Full Text] [Related]
5. Epidemiology of leprosy. Gimenez MM Acta Leprol; 1979; (75):7-33. PubMed ID: 121021 [No Abstract] [Full Text] [Related]
6. BCG vaccination in leprosy. Price JE Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):205-12. PubMed ID: 6749707 [No Abstract] [Full Text] [Related]
7. Current epidemiology of leprosy in India. Rao PS Lepr Rev; 2006 Dec; 77(4):292-4. PubMed ID: 17343215 [No Abstract] [Full Text] [Related]
8. An approach to understanding the transmission of Mycobacterium leprae using molecular and immunological methods: results from the MILEP2 study. Smith WC; Smith CM; Cree IA; Jadhav RS; Macdonald M; Edward VK; Oskam L; van Beers S; Klatser P Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):269-77. PubMed ID: 15485283 [TBL] [Abstract][Full Text] [Related]
9. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients. Kaur I; Dogra S; Kumar B; Radotra BD Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965 [TBL] [Abstract][Full Text] [Related]
10. Vaccine trials against leprosy. Gupte MD Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):587-9. PubMed ID: 10347583 [No Abstract] [Full Text] [Related]
11. Extended studies on subclinical infection in leprosy. Bharadwaj VP; Ramu G; Desikan KV; Katoch K Indian J Lepr; 1984; 56(4):807-12. PubMed ID: 6398341 [No Abstract] [Full Text] [Related]
13. Fluorescent leprosy antibody absorption (FLA-ABS) test for detecting subclinical infection with Mycobacterium leprae. Abe M; Minagawa F; Yoshino Y; Ozawa T; Saikawa K; Saito T Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):109-19. PubMed ID: 6156918 [No Abstract] [Full Text] [Related]
14. An update on the diagnosis and treatment of leprosy. Moschella SL J Am Acad Dermatol; 2004 Sep; 51(3):417-26. PubMed ID: 15337986 [No Abstract] [Full Text] [Related]
15. Peroxidase in therapy of experimentally induced leprosy. Maslov AK; Luzhnova SA; Kalyanina OV Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):49-52. PubMed ID: 11480320 [No Abstract] [Full Text] [Related]
16. A study of relapse after MDT in a district in West Bengal, India. Haldar A; Mahapatra BS; Mundle M; Haldar S; Saha AK Indian J Lepr; 2003; 75(1):1-8. PubMed ID: 15253389 [TBL] [Abstract][Full Text] [Related]
17. Mycobacterium leprae particle agglutination in diagnosis and monitoring of treatment of leprosy. Kampirapap K J Med Assoc Thai; 1999 Oct; 82(10):1020-4. PubMed ID: 10561966 [TBL] [Abstract][Full Text] [Related]
18. Leprosy at a turning point? Harboe M Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095 [No Abstract] [Full Text] [Related]